News

Video

Rare Gene Fusions in Pancreatic Cancer: Recent Updates in Biomarker and Drug Development

Related Videos
Laahn Ho Foster, MD
David C. Fisher, MD
Michel Ducreux, MD, PhD, head, Gastrointestinal Oncology Unit, head, Gastrointestinal Oncology Tumor Board, Gustave Roussy; professor, oncology, Paris-Saclay University
Meletios A. Dimopoulos, MD
Sandra Mazzoni, DO
Related Content
Paula Rodriguez-Otero, MD
October 23rd 2024

SC Daratumumab Plus VRd Earns EU Approval in Newly Diagnosed, Transplant-Eligible Myeloma

Samuel A. Kareff, MD, MPH, outgoing chief fellow, hematology and medical oncology, University of Miami Sylvester Comprehensive Cancer Center/Jackson Memorial Hospital
October 21st 2024

Phase 1 Trials Provide Oncology Fellows With Valuable Clinical Research Experience: With Samuel A. Kareff, MD, MPH

Noman Ashraf, MD
October 23rd 2024

ADCs Redefine HER2+ NSCLC Landscape With Potential to Shift to the Frontline Setting

Francine Foss, MD, professor, medicine (hematology) and dermatology, director, Multidisciplinary T Cell Lymphoma Program, Yale School of Medicine; scientific leader, Lymphoma CRT, Yale Cancer Center
October 17th 2024

FDA Approval Insights: Denileukin Diftitox in Relapsed/Refractory CTCL

Neal Shore, MD, FACS, of Carolina Urologic Research Center
October 23rd 2024

First-in-Class Bicycle Toxin Conjugate Targeting Nectin-4 Generates Excitement in Urothelial Carcinoma

Paula G. O’Connor, MD, chief medical officer, Nurix Therapeutics
October 22nd 2024

NX-5948 Generates Responses in R/R Waldenström Macroglobulinemia